Work

Pretherapeutic first-in-human targeting trial of anti-hK2 antibody h11B6: A potential molecular vector for alpha-particle radioimmunotherapy.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.6_suppl.122

Authors: Michael J. Morris, Joseph A. O' Donoghue, Dushen Chetty, Steven Max, Danielle Wanik, Mike Russell, Tenzin Nyima, Anjali Narayan Avadhani, Chaitanya R Divgi, Neeta Pandit-Taskar

Institutions: Memorial Sloan Kettering Cancer Center, Invicro (United States)

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Janssen Research and Development

OpenAlex ID: W3134094227

Cites:

Cited by: 1

Related to: 10